Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional genomics to uncover drug mechanism of action
Sebastian Nijman
Nature Chemical Biology (2015) Vol. 11, Iss. 12, pp. 942-948
Closed Access | Times Cited: 75

Showing 26-50 of 75 citing articles:

Advances in fungal chemical genomics for the discovery of new antifungal agents
Alice Xue, Nicole Robbins, Leah E. Cowen
Annals of the New York Academy of Sciences (2020) Vol. 1496, Iss. 1, pp. 5-22
Open Access | Times Cited: 29
A Tale of Two Tails: Efficient Profiling of Protein Degraders by Specific Functional and Target Engagement Readouts
Alexey Chernobrovkin, Cindy Cázares-Körner, Tomas Friman, et al.
SLAS DISCOVERY (2021) Vol. 26, Iss. 4, pp. 534-546
Open Access | Times Cited: 25
A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetate
Sébastien Dubuis, Karin Ortmayr, Mattia Zampieri
Communications Biology (2018) Vol. 1, Iss. 1
Open Access | Times Cited: 32
A quantitative shRNA screen identifies ATP1A1 as a gene that regulates cytotoxicity by aurilide B
Shohei Takase, Rumi Kurokawa, Daisuke Arai, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 30
Challenging transcription by DNA-binding antitumor drugs
José Portugal
Biochemical Pharmacology (2018) Vol. 155, pp. 336-345
Closed Access | Times Cited: 25
Inverse Drug Discovery identifies weak electrophiles affording protein conjugates
Gabriel M. Kline, Karina Nugroho, Jeffery W. Kelly
Current Opinion in Chemical Biology (2022) Vol. 67, pp. 102113-102113
Open Access | Times Cited: 13
Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition
Akito Ono, Osamu Sano, Ken‐ichi Kazetani, et al.
PLoS ONE (2017) Vol. 12, Iss. 7, pp. e0181243-e0181243
Open Access | Times Cited: 24
Multiscale modelling of drug mechanism and safety
Jitao David Zhang, Lisa Sach-Peltason, Christian Krämer, et al.
Drug Discovery Today (2019) Vol. 25, Iss. 3, pp. 519-534
Open Access | Times Cited: 21
From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems
Quentin T. L. Pasquer, Ioannis Tsakoumagkos, Sascha Hoogendoorn
Molecules (2020) Vol. 25, Iss. 23, pp. 5702-5702
Open Access | Times Cited: 19
Innovating cancer drug discovery with refined phenotypic screens
Zhenyi Wang, Alžbeta Hulı́ková, Pawel Swietach
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 8, pp. 723-738
Open Access | Times Cited: 2
Systematic Targeting of Protein Complexes with Molecular COUPLrs
Diane Yang, Stefan Harry, Harrison B. Chong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Whole-organism phenotypic screening for anti-infectives promoting host health
Anne E. Clatworthy, Keith P. Romano, Deborah T. Hung
Nature Chemical Biology (2018) Vol. 14, Iss. 4, pp. 331-341
Open Access | Times Cited: 19
Omics Technologies in the Plant–Microbe Interactions
Kubilay Kurtuluş Bastas, Ajay Kumar
Microorganisms for sustainability (2023), pp. 257-282
Closed Access | Times Cited: 6
Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin
Francisco J. García-Rodríguez, Carmen Martínez-Fernández, David Brena, et al.
Disease Models & Mechanisms (2018)
Open Access | Times Cited: 17
Detection of functional protein domains by unbiased genome-wide forward genetic screening
Mareike Herzog, Fabio Puddu, Julia Coates, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 17
A new class of HIV-1 inhibitors and the target identification via proteomic profiling
Yingzi Ge, Bin Zhou, Ruoxuan Xiao, et al.
Science China Chemistry (2018) Vol. 61, Iss. 11, pp. 1430-1439
Closed Access | Times Cited: 16
Mining the Potential of Label-Free Biosensors for In Vitro Antipsychotic Drug Screening
Tuğba Kiliç, Maria Soler, Nafiseh Fahimi-Kashani, et al.
Biosensors (2018) Vol. 8, Iss. 1, pp. 6-6
Open Access | Times Cited: 14
enAsCas12a Enables CRISPR-Directed Evolution to Screen for Functional Drug Resistance Mutations in Sequences Inaccessible to SpCas9
Jasper E. Neggers, Maarten Jacquemyn, Tim Dierckx, et al.
Molecular Therapy (2020) Vol. 29, Iss. 1, pp. 208-224
Open Access | Times Cited: 12
Network-assisted target identification for haploinsufficiency and homozygous profiling screens
Sheng Wang, Jian Peng
PLoS Computational Biology (2017) Vol. 13, Iss. 6, pp. e1005553-e1005553
Open Access | Times Cited: 12
Identification of Protein Targets of Bioactive Small Molecules Using Randomly Photomodified Probes
Petr Šimon, Tomáš Knedlík, Kristýna Blažková, et al.
ACS Chemical Biology (2018) Vol. 13, Iss. 12, pp. 3333-3342
Closed Access | Times Cited: 12
Systematic Identification of Pharmacological Targets from Small-Molecule Phenotypic Screens
Xueping Liu, Hoeke A. Baarsma, Chung Hwee Thiam, et al.
Cell chemical biology (2016) Vol. 23, Iss. 10, pp. 1302-1313
Closed Access | Times Cited: 10
Targeting Cdc42 with the anticancer compound MBQ-167 inhibits cell polarity and growth in the budding yeast S. cerevisiae
Michael J. Rivera-Robles, Julia Medina‐Velázquez, Gabriela M. Asencio-Torres, et al.
Small GTPases (2018) Vol. 11, Iss. 6, pp. 430-440
Open Access | Times Cited: 10
Genomic Approaches to Antifungal Drug Target Identification and Validation
Nicole Robbins, Leah E. Cowen
Annual Review of Microbiology (2022) Vol. 76, Iss. 1, pp. 369-388
Open Access | Times Cited: 6
Gain- and Loss-of-Function Screens Coupled to Next-Generation Sequencing for Antibiotic Mode of Action and Resistance Studies in Streptococcus pneumoniae
Hélène Gingras, Kévin Patron, Arijit Bhattacharya, et al.
Antimicrobial Agents and Chemotherapy (2019) Vol. 63, Iss. 5
Open Access | Times Cited: 8
Crosstalk between Receptor and Non-receptor Mediated Chemical Modes of Action in Rat Livers Converges through a Dysregulated Gene Expression Network at Tumor Suppressor Tp53
Karen Funderburk, Scott S. Auerbach, Pierre R. Bushel
Frontiers in Genetics (2017) Vol. 8
Open Access | Times Cited: 6

Scroll to top